VITASPRING BIOMEDICAL CO. LTD.

Other languages VitaSpring Biomedical Co. Ltd.

Equities

VSBC

US92851B1026

Market Closed - OTC Markets Other stock markets 02:03:41 2023-08-11 pm EDT			5-day change	1st Jan Change
15 ^USD	+36.24%		-.--%	-.--%

2022	VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2022	CI
2022	VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2022	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2022	22-12-21
VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2022	22-09-15
VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the First Quarter Ended April 30, 2022	22-06-15
VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the Full Year Ended January 31, 2022	22-05-03
VitaSpring Biomedical Co. Ltd. Auditor Raises 'Going Concern' Doubt	22-05-02
VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2021	21-12-23
Vitaspring Biomedical Co. Ltd. Reports Earnings Results for the Second Quarter Ended July 31, 2021	21-09-15
Vitaspring Biomedical Co. Ltd. Reports Earnings Results for the First Quarter Ended April 30, 2021	21-06-14
VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the Full Year Ended January 31, 2021	21-04-14
Vitaspring Biomedical Co. Ltd. Reports Earnings Results for the Third Quarter Ended October 31, 2020	20-12-15
Vitaspring Biomedical Co. Ltd. Reports Earnings Results for the Second Quarter Ended July 31, 2020	20-09-28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer